Oncolytics Biotech
ONCY
#10307
Rank
A$75.46 M
Marketcap
A$0.58
Share price
-5.23%
Change (1 day)
-65.45%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of June 2026 : A$5.87 Million

According to Oncolytics Biotech 's latest financial reports the company has A$5.87 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$7.76 M-56.4%
2024-12-31A$17.81 M-53.89%
2023-12-31A$38.62 M11.01%
2022-12-31A$34.79 M-22.05%
2021-12-31A$44.63 M40.19%
2020-12-31A$31.84 M105.82%
2019-12-31A$15.46 M8.35%
2018-12-31A$14.27 M18.43%
2017-12-31A$12.05 M-17.29%
2016-12-31A$14.57 M-43.49%
2015-12-31A$25.79 M51.42%
2014-12-31A$17.03 M-40.56%
2013-12-31A$28.66 M39.16%
2012-12-31A$20.59 M-38.14%
2011-12-31A$33.29 M-21.16%
2010-12-31A$42.23 M16.4%
2009-12-31A$36.28 M134.65%
2008-12-31A$15.46 M-46.9%
2007-12-31A$29.12 M-3.1%
2006-12-31A$30.05 M-36.79%
2005-12-31A$47.54 M30.41%
2004-12-31A$36.46 M69.35%
2003-12-31A$21.53 M129.55%
2002-12-31A$9.37 M-49.1%
2001-12-31A$18.42 M-12.32%
2000-12-31A$21.01 M339.66%
1999-12-31A$4.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
A$12.77 B 217,396.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$15.80 B 268,842.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
A$1.39 B 23,628.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
A$39.69 M 575.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$5.21 B 88,721.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
A$0.11 B 1,780.87%๐Ÿ‡บ๐Ÿ‡ธ USA